| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56ee5285e8e8edccb061046ff20da7a6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
1990-08-23^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1992-10-27^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99e25c52b2d1828eadcb1ab1065c53cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95544e2ed0162393e3834540e345a866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caaa31c8da5d97bbc90b528c802de10a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b22c9ea0acf783642c5c0eb47e378781 |
| publicationDate |
1992-10-27^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5158942-A |
| titleOfInvention |
Process of using phospholipid derivatives to inhibit multiplication of the human immunodeficiency virus |
| abstract |
The present invention is concerned with the use of compounds of the general formula: <IMAGE> (I) and of the pharmacologically acceptable salts thereof, as well as of the optical isomers thereof for the preparation of pharmaceutical compositions with antiviral action. The present invention also provides new phospholipid derivatives. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10954255-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6602861-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5846955-A |
| priorityDate |
1989-09-02^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |